As director of a large academic research institute, encompassing nine departments and seven cross-disciplinary research centers, Stephen Desiderio, M.D., Ph.D., is uniquely positioned to comment on the effects of sequestration on top research institutions like Johns Hopkins. In fact, Johns Hopkins is the institution receiving the most NIH funding for FY2013.
Desiderio has several personal stories to tell, and can also give specifics regarding the impact of sequestration at an institutional level.
Desiderio is a professor of molecular biology and genetics at the Johns Hopkins University School of Medicine. He directs the Johns Hopkins Institute for Basic Biomedical Sciences and the Immunobiology Program in the Institute for Cell Engineering.
Broadcast studio arrangements can be made by contacting Catherine Kolf at [email protected] or 443-287-2251.
RSS